Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4918961 | 1.00 | TSHR (0.47) | TSHRTDP1CA2CA5ACA5B | |
| SCHEMBL3781 | 0.84 | — | — | |
| SCHEMBL56331 | 0.84 | CA2 (0.54) | TSHRTDP1CA2CA5ACA5B | |
| SCHEMBL6905632 | 0.81 | CA2 (0.50) | TSHRTDP1CA2CA5ACA5B | |
| Methane SCHEMBL7363776 | 0.81 | CA2 (0.50) | TSHRTDP1CA2CA5ACA5B | |
| Water SCHEMBL2456364 | 0.81 | CA2 (0.50) | TSHRTDP1CA2CA5ACA5B | |
| Phosphine SCHEMBL10457030 | 0.81 | CA2 (0.50) | TSHRTDP1CA2CA5ACA5B | |
| Sulfuric Acid SCHEMBL560688 | 0.81 | CA5A (0.55) | TSHRTDP1CA2CA5ACA5B | |
| SCHEMBL10495537 | 0.81 | CA2 (0.50) | TSHRTDP1CA2CA5ACA5B | |
| Water SCHEMBL10934974 | 0.81 | CA2 (0.50) | TSHRTDP1CA2CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118221653-A | Organic compound, organic light emitting diode including the same, and display device including the organic light emitting diode | 秀博瑞殷株式公社 | 2024-06-21 | — | — | CN | disclosed |
| CN-117736156-A | Organic compound, organic light emitting diode including the same, and display device including the organic light emitting diode | 秀博瑞殷株式公社 | 2024-03-22 | — | — | CN | disclosed |
| CN-114945563-A | Organic compound, organic light emitting diode including the same, and display device including the organic light emitting diode | 秀博瑞殷株式公社 | 2022-08-26 | — | — | CN | disclosed |
| CN-114599646-A | Organic compound, organic light emitting diode including the same, and display device including the organic light emitting diode | 秀博瑞殷株式公社 | 2022-06-07 | — | — | CN | disclosed |
| US-10476008-B2 | Compound for organic optoelectric device and organic optoelectric device and display device | SAMSUNG SDI CO., LTD. (KR) | 2019-11-12 | — | — | US | disclosed |
| US-20170317293-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20100324017-A1 | ACYLGUANIDINE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-2119704-A1 | ACYLGUANIDINE DERIVATIVE | Astellas Pharma Inc. (JP) | 2009-11-18 | — | — | EP | disclosed |
| US-20080051433-A1 | Pyrrole-3-Carboxamide Derivatives for the Treatment of Obesity | ASTRAZENECA (SE) | 2008-02-28 | — | — | US | disclosed |
| EP-1718610-A1 | PYRROLE-3-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF OBESITY | AstraZeneca AB (SE) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005080328-A1 | PYRROLE-3-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF OBESITY | ASTRAZENECA AB (SE) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324017-A1 | ACYLGUANIDINE DERIVATIVE | HTR5A, GRM5, HTR1E | TSHR 944/4885TDP1 541/4885CA2 4275/4885 |
| US-20170317293-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | OXER1, OCIAD1, OR10J3 | TSHR 3796/4885TDP1 2769/4885CA2 1520/4885 |
| US-10476008-B2 | Compound for organic optoelectric device and organic optoelectric device and display device | OXER1, OCIAD1, OR10J3 | TSHR 3796/4885TDP1 2769/4885CA2 1520/4885 |
| US-20080051433-A1 | Pyrrole-3-Carboxamide Derivatives for the Treatment of Obesity | PC, GPR119, PGC | TSHR 1599/4885TDP1 2965/4885CA2 3869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.